BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Front Med (Lausanne) 2020;7:448. [PMID: 32974366 DOI: 10.3389/fmed.2020.00448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kulkarni AV, Tevethia HV, Arab JP, Candia R, Premkumar M, Kumar P, Sharma M, Reddy DN, Padaki NR. Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2021;45:101675. [PMID: 33722778 DOI: 10.1016/j.clinre.2021.101675] [Reference Citation Analysis]
2 Cardoso AC, Tovo CV, Leite NC, El Bacha IA, Calçado FL, Coral GP, Sammarco GN, Cravo C, Carvalho Filho RJ, de Mello Perez R, Luiz RR, Parise ER, Villela-nogueira CA. Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease. Dig Dis Sci. [DOI: 10.1007/s10620-021-07363-x] [Reference Citation Analysis]
3 Ajah AA, Lembede BW, Nkomozepi P, Erlwanger KH, Nyakudya TT. Neonatal Oral Administration of Chrysin Prevents Long-Term Development of Non-Alcoholic Fatty Liver Disease in a Sexually Dimorphic Manner in Fructose Nurtured Sprague Dawley Rats. Life 2022;12:790. [DOI: 10.3390/life12060790] [Reference Citation Analysis]
4 Rim JH, Youk T, Gee HY, Cho J, Yoo J. Dynamic Chronological Changes in Serum Triglycerides Are Associated With the Time Point for Non-alcoholic Fatty Liver Disease Development in the Nationwide Korean Population Cohort. Front Med (Lausanne) 2021;8:637241. [PMID: 33777980 DOI: 10.3389/fmed.2021.637241] [Reference Citation Analysis]
5 Amanatidou AI, Kaliora AC, Amerikanou C, Stojanoski S, Milosevic N, Vezou C, Beribaka M, Banerjee R, Kalafati IP, Smyrnioudis I, Kurth MJ, Kannt A, Francino MP, Visvikis-Siest S, Deloukas P, Llorens C, Marascio F, Milic N, Medic-Stojanoska M, Gastaldelli A, Trivella MG, Dedoussis GV. Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study. Int J Environ Res Public Health 2022;19:971. [PMID: 35055797 DOI: 10.3390/ijerph19020971] [Reference Citation Analysis]
6 Semmler G, Datz C, Reiberger T, Trauner M. Diet and exercise in NAFLD/NASH: Beyond the obvious. Liver Int 2021. [PMID: 34328248 DOI: 10.1111/liv.15024] [Reference Citation Analysis]
7 Cabrera D, Rao I, Raasch F, Solis N, Pizarro M, Freire M, Sáenz De Urturi D, Ramírez CA, Triantafilo N, León J, Riquelme A, Barrera F, Baudrand R, Aspichueta P, Arrese M, Arab JP. Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice. Ann Hepatol 2021;24:100357. [PMID: 33940220 DOI: 10.1016/j.aohep.2021.100357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chang BY, Kim HJ, Kim TY, Kim SY. Enzyme-Treated Zizania latifolia Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 Pathway. Antioxidants (Basel) 2021;10:960. [PMID: 34203789 DOI: 10.3390/antiox10060960] [Reference Citation Analysis]
9 Arrese M, Arab JP, Barrera F, Kaufmann B, Valenti L, Feldstein AE. Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity. Semin Liver Dis 2021. [PMID: 34233370 DOI: 10.1055/s-0041-1730927] [Reference Citation Analysis]
10 Osei TB, van Dijk AM, Dingerink S, Chilunga FP, Beune E, Meeks KAC, Bahendeka S, Schulze MB, Agyemang C, Nicolaou M, Holleboom AG, Danquah I. Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study. Nutrients 2021;13:3679. [PMID: 34835937 DOI: 10.3390/nu13113679] [Reference Citation Analysis]
11 Zhu Y, Peng Z, Lu Y, Li H, Zeng X, Zhang Z, Li X, Hu C, Hu A, Zhao Q, Wang H, Yang W. Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis. Liver Int 2021. [PMID: 34521152 DOI: 10.1111/liv.15057] [Reference Citation Analysis]
12 Karimi-Sales E, Mohaddes G, Alipour MR. Hepatoprotection of capsaicin in alcoholic and non-alcoholic fatty liver diseases. Arch Physiol Biochem 2021;:1-11. [PMID: 34396890 DOI: 10.1080/13813455.2021.1962913] [Reference Citation Analysis]
13 Köhler N, Höring M, Czepukojc B, Rose TD, Buechler C, Kröhler T, Haybaeck J, Liebisch G, Pauling JK, Kessler SM, Kiemer AK. Kupffer cells are protective in alcoholic steatosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022. [DOI: 10.1016/j.bbadis.2022.166398] [Reference Citation Analysis]
14 Lee I. Regulation of Cytochrome c Oxidase by Natural Compounds Resveratrol, (-)-Epicatechin, and Betaine. Cells 2021;10:1346. [PMID: 34072396 DOI: 10.3390/cells10061346] [Reference Citation Analysis]
15 Dai YN, Xu CF, Pan HY, Huang HJ, Chen MJ, Li YM, Yu CH. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease. World J Clin Cases 2022; 10(13): 4097-4109 [DOI: 10.12998/wjcc.v10.i13.4097] [Reference Citation Analysis]
16 Jarvis H, O'Keefe H, Craig D, Stow D, Hanratty B, Anstee QM. Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis. BMJ Open 2022;12:e049767. [PMID: 34983755 DOI: 10.1136/bmjopen-2021-049767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cherubini A, Casirati E, Tomasi M, Valenti L. PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date. Expert Opin Ther Targets 2021;:1-11. [PMID: 34904923 DOI: 10.1080/14728222.2021.2018418] [Reference Citation Analysis]
18 Kulkarni AV, Rabiee A, Mohanty A. Management of Portal Hypertension. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Li D, Hu Z, He Q, Guo Y, Chong Y, Xu J, Qin L. Lactoferrin Alleviates Acute Alcoholic Liver Injury by Improving Redox-Stress Response Capacity in Female C57BL/6J Mice. J Agric Food Chem 2021;69:14856-67. [PMID: 34873911 DOI: 10.1021/acs.jafc.1c06813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kim RG, Medina SP, Magee C, Khalili M. Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations. Hepatol Commun 2021. [PMID: 34792300 DOI: 10.1002/hep4.1873] [Reference Citation Analysis]
21 Han S, Yang Z, Zhang T, Ma J, Chandler K, Liangpunsakul S. Epidemiology of Alcohol-Associated Liver Disease. Clin Liver Dis 2021;25:483-92. [PMID: 34229835 DOI: 10.1016/j.cld.2021.03.009] [Reference Citation Analysis]
22 Huang Y, Wang X, Zhang L, Zheng K, Xiong J, Li J, Cong C, Gong Z, Mao J. Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease. Comput Math Methods Med 2022;2022:7888076. [PMID: 35677177 DOI: 10.1155/2022/7888076] [Reference Citation Analysis]